Position in JNJ
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$2,766,749
+$199,152 QoQ
Shares Held
10,894
+3.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#2,058
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Winthrop Advisory Group LLC holds $8,653,027 across 8 Drug Manufacturers - General names. JNJ ranks #1 (32.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
10,894 | $2,766,749 | |
| 2 | LLY |
ELI LILLY & Co
|
1,928 | $2,312,500 | |
| 3 | ABBV |
AbbVie Inc.
|
4,944 | $1,244,107 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,931 | $1,019,133 | |
| 5 | AMGN |
Amgen Inc
|
1,052 | $380,949 | |
| 6 | PFE |
Pfizer Inc
|
14,384 | $346,365 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,429 | $306,879 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,796 | $276,345 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,766,749 | 10,894 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $2,567,597 | 10,504 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2,177,320 | 10,521 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,767,979 | 9,535 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $1,400,412 | 9,168 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,560,056 | 9,407 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,304,906 | 9,023 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,494,355 | 9,221 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $1,380,627 | 9,446 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,495,844 | 9,456 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $1,358,622 | 8,668 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,381,814 | 8,872 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $1,474,617 | 8,909 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,383,220 | 8,924 | Shares | Sole | 2023-08-01 | |
| 2022-12-31 | $1,776,745 | 10,058 | Shares | Sole | 2023-08-03 | |
| 2022-09-30 | $1,605,665 | 9,829 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,752,556 | 9,873 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,611,020 | 9,090 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $1,499,428 | 8,765 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $1,409,087 | 8,725 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,463,714 | 8,885 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $1,483,423 | 9,026 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,282,961 | 8,152 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,202,206 | 8,075 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $1,101,836 | 7,835 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $1,026,485 | 7,828 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||